Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

被引：0
|
作者：
Chang, Andres [1 ,2 ]
Lai, Lilin [2 ,3 ,4 ]
Akhtar, Akil [2 ]
Linderman, Susanne [2 ]
Orellana-Noia, Victor [1 ]
Saini, Manpreet [2 ,5 ]
Valanparambil, Rajesh [2 ]
Blum, Kristie [1 ]
Allen, Pamela [1 ]
Lechowicz, Mary [1 ]
Romancik, Jason [1 ]
Ayers, Amy [1 ,6 ]
O'Leary, Colin [1 ]
Churnetski, Michael [1 ]
Kives, Melissa [1 ]
Nooka, Ajay [1 ]
Koff, Jean [1 ]
Dhodapkar, Madhav [1 ]
Suthar, Mehul [2 ,3 ]
Cohen, Jonathon [1 ]
Ahmed, Rafi [2 ]
机构：
[1] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA
[2] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Sch Med, Atlanta, GA USA
[3] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA
[4] Yerkes Natl Primate Res Ctr, Atlanta, GA USA
[5] Int Ctr Genet Engn & Biotechnol ICGEB, New Delhi, India
[6] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
CLL; non-Hodgkin; lymphoma; chronic lymphocytic leukemia; COVID-19; SARS-CoV-2; vaccine;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-515
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [31] Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients
    Oyaert, Matthijs
    De Scheerder, Marie-Angelique
    Van Herrewege, Sophie
    Laureys, Guy
    Van Assche, Sofie
    Cambron, Melissa
    Naesens, Leslie
    Hoste, Levi
    Claes, Karlien
    Haerynck, Filomeen
    Kerre, Tessa
    Van Laecke, Steven
    Jacques, Peggy
    Padalko, Elizaveta
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (01) : 177 - 185
  • [32] Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients
    Gupta, Sudhir
    Su, Houfen
    Agrawal, Sudhanshu
    Demirdag, Yesim
    Tran, Michelle
    Gollapudi, Sastry
    PATHOGENS, 2024, 13 (06):
  • [33] Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma
    Dennie, Trevor W.
    Kolesar, Jill M.
    CLINICAL THERAPEUTICS, 2009, 31 : 2290 - 2311
  • [34] Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia
    Sorcini, Daniele
    De Falco, Filomena
    Gargaro, Marco
    Bozza, Silvia
    Guarente, Valerio
    Cardinali, Valeria
    Stella, Arianna
    Adamo, Francesco Maria
    Silva Barcelos, Estevao Carlos
    Rompietti, Chiara
    Dorillo, Erica
    Geraci, Clelia
    Esposito, Angela
    Arcaleni, Roberta
    Capoccia, Silvia
    Mameli, Maria Grazia
    Graziani, Alessandro
    Moretti, Lorenzo
    Cipiciani, Alessandra
    Riccardi, Carlo
    Mencacci, Antonella
    Fallarino, Francesca
    Rosati, Emanuela
    Sportoletti, Paolo
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 45 - 57
  • [35] Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma
    Reyes, Carolina
    Engel-Nitz, Nicole M.
    Byfield, Stacey DaCosta
    Ravelo, Arliene
    Ogale, Sarika
    Bancroft, Tim
    Anderson, Amy
    Chen, May
    Matasar, Matthew
    ONCOLOGIST, 2019, 24 (09) : 1219 - 1228
  • [36] SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study
    Mak, Willem A.
    Koeleman, Johannes G. M.
    van der Vliet, Marijke
    Keuren, Frans
    Ong, David S. Y.
    JOURNAL OF INFECTION, 2022, 84 (02) : 171 - 178
  • [37] Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination
    Abdallah, Al-Ola
    Mahmoudjafari, Zahra
    Atieh, Tahani
    Ahmed, Nausheen
    Cui, Wei
    Shune, Leyla
    Mohan, Meera
    McGuirk, Joseph
    Remker, Cassie
    Foss, Margaret
    Karloff, Ellie
    Fitch, Heather
    Atrash, Shebli
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (05) : 458 - 464
  • [38] The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
    Rahimi, Farid
    Bezmin Abadi, Amin Talebi
    FUTURE VIROLOGY, 2021, 16 (12) : 781 - 784
  • [39] Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
    Ricketson, Leah J.
    Doucette, Emily J.
    Alatorre, Isabella
    Tarannum, Tarannum
    Gray, Joslyn
    Booth, William
    Tipples, Graham
    Charlton, Carmen
    Kanji, Jamil N.
    Fonseca, Kevin
    Kellner, James D.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [40] Vaccination After SARS-CoV-2 Infection Increased Antibody Avidity Against the Omicron Variant Compared to Vaccination Alone
    LeMaster, Cas
    Geanes, Eric S.
    Fraley, Elizabeth R.
    Selvarangan, Rangaraj
    Bradley, Todd
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10) : 1712 - 1716
12345